Back to
MAVERICK CAPITAL LTD
ALNY12 quarters
Position history for
MAVERICK CAPITAL LTD's holdings in ALNYLAM PHARMACEUTICALS INC
No. Maverick Capital exited its ALNY (Alnylam Pharmaceuticals) position in Q4 2021. Its Q3 2021 13F listed 3,983 shares worth $752,000. Maverick Capital already held ALNY in its Q1 2019 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$300M
Total Shares Change
-3.2M
Quarter-by-Quarter History
Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors